Jeanette M. Broering, Ph.D.
Affiliations: | 2012 | Nursing | University of California, San Francisco, San Francisco, CA |
Area:
Nursing, Oncology, AgingGoogle:
"Jeanette Broering"Parents
Sign in to add mentor| Christine Miaskowski | grad student | 2012 | UCSF | |
| (Measurement Bias with Mixed-mode Patient-reported Outcome (PRO) Survey Administration: Measurement Equivalence, Cost, and Data Quality.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Braun AE, Chan JM, Neuhaus J, et al. (2024) The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer. Cancer |
| Herlemann A, Cowan JE, Washington SL, et al. (2023) Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer. European Urology |
| Washington SL, Lonergan PE, Cowan JE, et al. (2023) Ten-year work burden after prostate cancer treatment. Cancer Medicine |
| Baskin A, Cowan JE, Braun A, et al. (2023) Long-term complications and health-related quality of life outcomes after radical prostatectomy with or without subsequent radiation treatment for prostate cancer. Urologic Oncology |
| Lonergan PE, Baskin A, Greenberg SA, et al. (2023) The long-term incidence and quality of life outcomes associated with treatment-related toxicities of external beam radiotherapy for prostate cancer. Urology |
| Langlais CS, Graff RE, Van Blarigan EL, et al. (2023) Post-diagnostic health behaviour scores and risk of prostate cancer progression and mortality. British Journal of Cancer |
| Smith LH, García-Albéniz X, Chan JM, et al. (2022) Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formula. European Journal of Epidemiology |
| Weng X, Zhong L, Xiang P, et al. (2022) Cost-effectiveness analysis of primary treatments for localised prostate cancer: A population-based Markov analysis using real-world evidence. European Journal of Cancer Care. e13740 |
| Lonergan PE, Washington SL, Cowan JE, et al. (2021) Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer. The Journal of Urology. 101097JU000000000000 |
| Langlais CS, Chan JM, Kenfield SA, et al. (2021) Post-diagnostic coffee and tea consumption and risk of prostate cancer progression by smoking history. Cancer Causes & Control : Ccc |